Literature DB >> 9463569

Trefoil factor family domain peptides.

G R Williams1, N A Wright.   

Abstract

Within the past 15 years a new family of peptides has been identified, known as trefoil factor family (TFF) domain peptides; they are associated with mucin-secreting epithelial cells and synthesised predominantly in the gastrointestinal tract. They share a highly conserved physical structure, and their role in mucosal defence and healing is becoming increasingly clear, more recently a tumour suppressor function has been postulated. Outside the gastrointestinal tract, members of this group of peptides have also been identified in the normal hypothalamus and pituitary, and in normal breast tissue where it is responsive to oestrogen stimulation. Evidence of peptide expression has been found in a range of urological, gynaecological, gastrointestinal, pulmonary and breast carcinomas, and in the last two it appears to carry prognostic significance. The present review aims to summarise the rapidly expanding data on the role of these peptides in epithelial inflammation, repair and neoplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9463569     DOI: 10.1007/s004280050102

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  9 in total

1.  Targeting Hypoxia to Augment Mucosal Barrier Function.

Authors:  Caleb J Kelly; Sean P Colgan
Journal:  J Epithel Biol Pharmacol       Date:  2012-01-16

2.  Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa.

Authors:  H Ota; M Hayama; M Momose; Hala M T El-Zimaity; K Matsuda; K Sano; F Maruta; N Okumura; T Katsuyama
Journal:  Histochem Cell Biol       Date:  2006-06-20       Impact factor: 4.304

3.  Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha.

Authors:  M P Ebert; J Hoffmann; C Haeckel; K Rutkowski; R M Schmid; M Wagner; G Adler; H U Schulz; A Roessner; W Hoffmann; P Malfertheiner
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 4.  GATA factors in gastrointestinal malignancy.

Authors:  Funmi Ayanbule; Narasimhaswamy S Belaguli; David H Berger
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

5.  Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.

Authors:  Haruhiko Okada; Makoto T Kimura; Dongfeng Tan; Kyoko Fujiwara; Jun Igarashi; Masatoshi Makuuchi; Ai-Min Hui; Masahiko Tsurumaru; Hiroki Nagase
Journal:  Int J Oncol       Date:  2005-02       Impact factor: 5.650

6.  Aberrant epithelial expression of trefoil family factor 2 and mucin 6 in Helicobacter pylori infected gastric antrum, incisura, and body and its association with antralisation.

Authors:  H H-X Xia; Y Yang; S K Lam; W M Wong; S Y Leung; S T Yuen; G Elia; N A Wright; B C-Y Wong
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds.

Authors:  Friedrich P Paulsen; Chee-Wai Woon; Deike Varoga; Anne Jansen; Fabian Garreis; Kristin Jäger; Marita Amm; Daniel K Podolsky; Philipp Steven; Nicholas P Barker; Saadettin Sel
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

8.  Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.

Authors:  Yuko Ishibashi; Hiroshi Ohtsu; Masako Ikemura; Yasuko Kikuchi; Takayoshi Niwa; Kotoe Nishioka; Yoshihiro Uchida; Hirona Miura; Susumu Aikou; Toshiaki Gunji; Nobuyuki Matsuhashi; Yasukazu Ohmoto; Takeshi Sasaki; Yasuyuki Seto; Toshihisa Ogawa; Keiichiro Tada; Sachiyo Nomura
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

9.  Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK.

Authors:  Ru-Mei Chen; Yi-Shiou Chiou; Qing-Yun Chong; Han-Ming Poh; Tuan-Zea Tan; Meng-Yi Zhang; Lan Ma; Tao Zhu; Vijay Pandey; Alan Prem Kumar; Peter E Lobie
Journal:  Int J Mol Sci       Date:  2019-12-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.